Photo used for illustrative purpose.
Volunteers in Abu Dhabi have begun taking part in Phase III clinical trials of the Russian adenovirus-based COVID-19 vaccine (Sputnik V).
Initially open to 500 volunteers, the trials are being conducted by the Department of Health - Abu Dhabi (DoH), with joint supervision by the UAE Ministry of Health and Prevention (MoHAP), with medical protocols handled by Abu Dhabi’s public health provider, the Abu Dhabi Health Services Company, SEHA.
The vaccine is being tested on healthy adults from various nationalities aged 18+ years, who live in Abu Dhabi, have not previously been infected with COVID-19, have not participated in any other COVID-19 vaccination trial, and have not suffered any communicable or severe respiratory diseases for at least 14 days.
Volunteers will receive two doses of the vaccine, administered 20 days apart, and will be monitored through regular visits and tele-consultations for 180 days after taking the vaccine, in line with the highest international standards.
Trials are being processed at Tawam Hospital in Al Ain under the clinical supervision of Consultant Physician (Infectious Diseases) Dr. Ahmed Al Hammadi.
The programme is being conducted under the Vaccine for Victory campaign. Residents can register at www.v4v.ae. Registered individuals will then be contacted to arrange an eligibility screening before beginning the trials.
Results from the first two phases of the trial, published in medical journal The Lancet, showed a stable humoral and cellular immune response had been achieved among volunteers, with no serious adverse events recorded.
The Phase III clinical trials taking place in the UAE form part of the trials that are taking place in Russia and elsewhere globally.
The vaccine was developed by the Gamaleya National Research Institute of Epidemiology and Microbiology of Ministry of Health of the Russian Federation.WAM
The total number of doses provided up to Thursday stands at 2,868,645 with a rate of vaccine distribution of 29.00 doses per 100 people.
Great efforts reflect the vision of delivering services and providing the vaccine to the citizens, says Hessa Tahlak.
The ministry added that over 4-6 weeks the vaccine rollout will be focused on elderly people and those with chronic diseases who are the most vulnerable to COVID-19.
At least 3,419 people have died in Turkey and 1,602 in government- and rebel-controlled parts of Syria, bringing the total to at least 5,021, officials and medical sources said.
The AFP cameraman captured a poignant picture of a Turkish father, Masoud Hanser, refusing to leave his dead daughter's hand under the rubble.
The two leaders engaged in friendly conversation and reviewed several topics of concern to UAE citizens, including the potential for maximising state gains.